A fast clip growth for BioAgri
• Agri biotech grew at 37% in FY 2009-10
• There are over 30 companies marketing Bt cotton seeds in India
• The segment will grow at an average of 26% in the next 5 years
Agri biotech is the third largest contributor to Indian biotech
industry in FY 2009-2010 with a total segment turnover of Rs 1,936
crore, accounting for almost 14 percent of the total biotech revenues.
Registering a growth of 37 percent over last year, BioAgri emerged the
industry's fastest growing segment. The fact that BioServices segment
dominated by exports faced minor setbacks on account of currency
fluctuations helped BioAgri gain lead. In FY 2008-09 BioServices with a
growth of 31 percent was the fastest growing industry segment.
India is the fourth largest country in the world with almost 8.4
million hectares of area under Bt cotton. On one side the area under Bt
cotton has been on increasing, on the other side the prices for Bt
seeds packets has been slightly on decline. This decline is because of
government's intervention and more companies launching different
technologies for producing Bt seeds.
The number of companies selling Bt cotton seeds in India has increased
dramatically over the last eight years since the first
commercialization in 2002. Today, there are over 30 companies marketing
Bt cotton seeds in the country.
Nuziveedu Seeds is the largest seller of Bt cotton seeds. The company
sold 70 lakh packets generating Rs 476.86 crore in revenues. Rasi Seeds
is the second largest contributor with Rs 358.78 crore in sales.
Nuziveedu has 25 percent of the market share while Rasi Seeds is close
second with 19 percent market share. Other significant players include
Ajeet Seeds, Ankur Seeds selling 12-20 lakh packets each in FY 2009-10.
||600 kg per hectare
||516 kg per hectare
||472 kg per hectare
||595 kg per hectare
A total of 280 lakh packets of seeds containing 450 grams were sold in
2009, approximately 87 percent being Bollgard II and 13 percent
bollgard I. An additional 20 lakh packets of spurious seeds were
estimated to have been sold illegally to the farmers mainly in Gujarat
state. While in most of the regions, the Bollgard I and Bollgard II
cotton seeds were priced at Rs 650 and Rs 750 respectively. In North
(mainly Punjab, Haryana and Rajasthan), the pricing was kept at Rs 759
for Bollgard I and Rs 925 for Bollgard II.
The “Bollgard” Bt cotton seeds were sold in nine states-Andhra Pradesh,
Tamil Nadu, Karnataka, Gujarat, Madhya Pradesh, Maharashtra, Haryana,
Punjab, and Rajasthan. Maharashtra leads as the largest selling state
with almost 90 lakh packets sold in the region followed by the South
(75 lakh packets) and North (45 lakh packets). The northern market is
mainly held by Shriram Bioseeds.
A region wise split shows that the Northern region of India recorded
maximum production of Bt cotton.
An important event of 2009 was the approval of MLS 9124, developed
indigenously by Metahelix Life Sciences. The product has a synthetic
cry 1C gene. The other development was the release of two cotton
hybrids namely MH 5124 and MH 5174 expressing the synthetic cry 1C gene
Notes: *Monsanto royalty has not been
taken into account as segment revenue
Top 10 Agri
Companies by Revenue (2009-10)
for next 5 years
• BioIndustrial grew 16% in FY
• 70% of the industrial enzyme
domestic demand is imported
|All figures in
Crore unless indicated otherwise
The BioIndustrial market mainly comprising industrial enzymes is
estimated to be Rs 564 crore in the year 2009-10 as against Rs 478
crore in 2008-09. The segment grew 16 percent in FY 2009-10. Though the
overall enzyme consumption figures of India are comparatively low with
respect to other countries and 60-70 percent of domestic demand is
imported, the segment on an average has been growing over 15 percent in
the last five years.
In India, the industrial enzyme consumption is predominantly in the
detergents market (40 percent), followed by the starch market (25
percent) . The other important segments are food and feed, textiles,
leather, pulp and paper. In recent years, enzymes have found numerous
applications in the food, pharmaceutical, diagnostic and chemical
processing industries. The trend for their application in almost every
is on increase.
The leading players in this segment include Novozymes which has over 50
percent market share followed by Advanced Enzyme Technologies holding
25-30 percent market share. Other important players are Maps, Genecor,
Lumis and Kerry Biosciences. Besides, a new entrant Anthem Cellutions,
a part of Anthem Biosciences group has gained significant market share
over a short period of time.
Apart from focusing on the local market, companies like Advanced Enzyme
Technologies are looking at other markets such as China. Considering
the potential opportunity in the other markets Advanced Enzyme has
registered good growth in its export sales.
The Indian companies are reporting a good growth, a lot of R&D is
happening in these companies and new applications are being explored.
Indian companies are looking at technologies from Europe, China and
However, with respect to global enzyme industry India still needs to do
a lot of catching up.
BioIndustrial Companies by Revenue (2009-10)
• Segment grows at 5%
• Domestic market contributes 68%
of BioInformatics revenue
(Revenue in Rs Cr)
(Revenue in Rs Cr)
||Novozymes South Asia*
||All figures in
Crore unless indicated otherwise
The smallest segment of the Industry, BioInformatics which has just
about 2 percent segment share in the overall industry, has been
sluggish in FY 2009-10. It registered a 5 percent growth over 2008-09,
clocking Rs 231 crore in revenues last year as compared to Rs 220
crore in FY 2008-09, when it recorded a growth of 16 percent.
The pure-play BioInformatics companies in India include Strand
Genomics, Ocimum Biosolutions, SysArris, CytoGenomics and
Molecular Connections. These companies have come out with products that
cater mainly to the needs of the pharmaceutical and biotechnology
companies. Most of these companies are small and medium enterprises
based at locations such as Bangalore, Hyderabad, Pune.
Top 3 BioInformatics Companies by Revenue (2009-10)
||Strand Life Sciences
figures in Rs. Crore unless indicated otherwise